- Filed
- May 10, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2017 · Apr 30, 2017 | 89.51M sh |
| Shares Diluted | Q1 2017 · Mar 31, 2017 | 88.26M sh |
| Shares Diluted | Q1 2017 · Mar 31, 2016 | 93.44M sh |
| Stock Repurchased | Q1 2017 · Mar 31, 2017 | $4.79M |
| Stock Repurchased | Q1 2017 · Mar 31, 2016 | $29.61M |
| Capex | Q1 2017 · Mar 31, 2017 | $3.58M |
| Capex | Q1 2017 · Mar 31, 2016 | $1.23M |
| Cash And Equivalents | Q1 2017 · Mar 31, 2017 | $183.32M |
| Cash And Equivalents | Q1 2017 · Dec 31, 2016 | $176.68M |
| Stockholders Equity | Q1 2017 · Mar 31, 2017 | $685.44M |
| Stockholders Equity | Q1 2017 · Dec 31, 2016 | $689.38M |
| Current Liabilities | Q1 2017 · Mar 31, 2017 | $88.58M |
| Current Liabilities | Q1 2017 · Dec 31, 2016 | $53.85M |
| Total Liabilities | Q1 2017 · Mar 31, 2017 | $398.95M |
| Total Liabilities | Q1 2017 · Dec 31, 2016 | $394.48M |
| Current Assets | Q1 2017 · Mar 31, 2017 | $279.14M |
| Current Assets | Q1 2017 · Dec 31, 2016 | $270.93M |
| Total Assets | Q1 2017 · Mar 31, 2017 | $1.08B |
| Total Assets | Q1 2017 · Dec 31, 2016 | $1.08B |
| Eps Diluted | Q1 2017 · Mar 31, 2017 | −$0.06 |
| Eps Diluted | Q1 2017 · Mar 31, 2016 | $0.00 |
| Eps Basic | Q1 2017 · Mar 31, 2017 | −$0.06 |
| Eps Basic | Q1 2017 · Mar 31, 2016 | $0.00 |
| Sga Expense | Q1 2017 · Mar 31, 2017 | $21.84M |
| Sga Expense restated | Q1 2017 · Mar 31, 2016 | $16.89M |
| Rd Expense | Q1 2017 · Mar 31, 2017 | $8.58M |
| Rd Expense restated | Q1 2017 · Mar 31, 2016 | $6.58M |
| Net Income | Q1 2017 · Mar 31, 2017 | −$5.25M |
| Net Income | Q1 2017 · Mar 31, 2016 | $283K |
| Operating Income | Q1 2017 · Mar 31, 2017 | −$3.57M |
| Operating Income restated | Q1 2017 · Mar 31, 2016 | $9.23M |
| Cost Of Revenue | Q1 2017 · Mar 31, 2017 | $63.19M |
| Cost Of Revenue restated | Q1 2017 · Mar 31, 2016 | $47.31M |
| Revenue | Q1 2017 · Mar 31, 2017 | $118.66M |
| Revenue restated | Q1 2017 · Mar 31, 2016 | $93.48M |